Anti-E-Cadherin Magnetic Beads Immunoprecipitation (IP) Kit

Temporarily not available outside of China.
Price:
Size:
Number:

抗E-Cadherin 磁気ビーズ免疫沈降(IP)キットの成分

Components Storage
Anti-E-Cadherin Magnetic Beads1,3 2-8℃ for 12 months
NP40 Cell Lysis Buffer2 -20℃ for 12 months
5×TBST(pH7.4)  
1×TBST(pH7.4)  
ddH2O  
Alkaline Elution Buffer 2-8℃ for 12 months
Acidity Elution Buffer 2-8℃ for 12 months
Neutralization Buffer 2-8℃ for 12 months

【1】The IP KIT contains anti-E-Cadherin magnetic Beads (2 mg/mL) in phosphate buffered saline (PBS, pH 7.4) with sodium azide (0.1%).

【2】Using NP-40 cell lysate buffer in the kit is required,otherwise,the magnetic beads may be precipitated.

【3】Shipping: Magnetic Beads kits are shipped at ambient temperature in which magnetic beads are provided in liquid buffer.

抗E-Cadherin 磁気ビーズ免疫沈降(IP)キットの製品説明

The Anti-E-Cadherin magnetic Beads, conjugated with Anti-E-Cadherin antibody, are used for immuneprecipitation (IP) of E-Cadherin proteins which expressed in vitro expression systems. For IP, the beads are added to a sample containing E-Cadherin proteins to form a bead-protein complex. The complex is removed from the solution manually using a magnetic separator. The bound E-Cadherin proteins are dissociated from the magnetic beads using an elution buffer.

抗E-Cadherin 磁気ビーズ免疫沈降(IP)キット抗体の情報

抗体
Anti-E-Cadherin Antibody(10204-T52)
免疫原
Recombinant Human E-Cadherin/CDH1 Protein (Catalog#10204-H08H)
交差反応
Human E-Cadherin/CDH1
ソース
Polyclonal Human Rabbit IgG
調製
Produced in rabbits immunized with purified, recombinant Human E-Cadherin/CDH1 (rh E-Cadherin/CDH1; Catalog#10204-H08H; NP_004351.1; Met1-Ile707). E-Cadherin/CDH1 specific IgG was purified by Human E-Cadherin/CDH1 affinity chromatography.
アプリケーション
Immunoprecipitation (IP), Minimum Protein Purification

Anti-E-Cadherin Magnetic Beads Immunoprecipitation (IP) Kit: 別名

Anti-Arc-1ALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-CD324ALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-CDH1ALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-CDHEALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-E-cadALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-E-CadherinALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-ECADALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-LCAMALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit; Anti-UVOALCAM Magnetic Beads-Immunoprecipitatiopn (IP) Kit

E-Cadherin 背景情報

Cadherins are calcium-dependent cell adhesion proteins which preferentially interact with themselves in a homophilic manner in connecting cells, and thus may contribute to the sorting of heterogeneous cell type. E-cadherin (E-Cad), also known as CDH1 and CD324, is a calcium-dependent cell adhesion molecule the intact function of which is crucial for the establishment and maintenance of epithelial tissue polarity and structural integrity. Mutations in CDH1 occur in diffuse type gastric cancer, lobular breast cancer, and endometrial cancer. In human cancers, partial or complete loss of E-cadherin expression correlates with malignancy. During apoptosis or with calcium influx, E-Cad is cleaved by the metalloproteinase to produce fragments of about 38 kDa (E-CAD/CTF1), 33 kDa (E-CAD/CTF2) and 29 kDa (E-CAD/CTF3), respectively. E-Cad has been identified as a potent invasive suppressor, as downregulation of E-cadherin expression is involved in dysfunction of the cell-cell adhesion system, and often correlates with strong invasive potential and poor prognosis of human carcinomas.
完全な名称
cadherin 1, type 1, E-cadherin (epithelial)
Related Pathways
  • Canonical Wnt Pathway
    Canonical Wnt Pathway
  • EGFR Signaling Pathway
    EGFR Signaling Pathway
参考文献
  • Wang HD, et al. (2004) CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol. 10(21): 3088-93.
  • Masterson J, et al. (2007) Posttranslational truncation of E-cadherin and significance for tumour progression. Cells Tissues Organs. 185(1-3): 175-9.
  • Mrgineanu E, et al. (2008) Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis. Rev Med Chir Soc Med Nat Iasi. 112(2): 432-6.
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください U.S.A.